Adolescent female assent in clinical trials: A model assent processMATTISON, Debra; VANDENBOSCH, Terry M; SOSKOLNE, Errol et al.Drug information journal. 2002, Vol 36, Num 1, pp 21-30, issn 0092-8615, 10 p.Article

Analysis of combination trials with no placebo armLAWRENCE, John.Drug information journal. 2002, Vol 36, Num 1, pp 151-156, issn 0092-8615, 6 p.Article

Analysis of drug safety data from clinical trialsCZARNECKI, Andrzej; ZALEWSKA, Katarzyna.Drug information journal. 2002, Vol 36, Num 1, pp 157-162, issn 0092-8615, 6 p.Article

Assessment of the immunotoxic potential of human pharmaceuticals: A workshop reportPUTMAN, Esther; VAN LOVEREN, Henk; BODE, Gerd et al.Drug information journal. 2002, Vol 36, Num 2, pp 417-427, issn 0092-8615, 11 p.Article

Compliance of clinical trial consent forms with international guidelines: Analysis of deficienciesLIN, Yeong-Liang; HUANG, Chia-Hsin; LIN, Chih-Liu et al.Drug information journal. 2002, Vol 36, Num 1, pp 17-19, issn 0092-8615, 3 p.Article

Current status and emerging opportunities in replacement of the lifetime mouse cancer bioassaySILVA-LIMA, Beatriz; VAN DER LAAN, Jan Willem.Drug information journal. 2002, Vol 36, Num 3, pp 645-657, issn 0092-8615, 13 p.Article

Current status of clinical trials in KenyaKIMANANI, Ebi.Drug information journal. 2002, Vol 36, Num 1, pp 31-39, issn 0092-8615, 9 p.Article

Effects of bias adjustment on actuarial survival curvesCHERNICK, Michael Ross; POULSEN, Erik; YONG WANG et al.Drug information journal. 2002, Vol 36, Num 3, pp 595-609, issn 0092-8615, 15 p.Article

Evaluation of published case reports' standards and notificationFERGUSON, Jeffrey A; MOCKBEE, Collen; ERBELE, Sara et al.Drug information journal. 2002, Vol 36, Num 2, pp 303-307, issn 0092-8615, 5 p.Article

Focused portfolio measures to support decision making throughout the pipelineSTEVEN, Sue E.Drug information journal. 2002, Vol 36, Num 3, pp 623-630, issn 0092-8615, 8 p.Article

Japanese perspectives on pharmaceutical product release rate testingKANIWA, Nahoko.Drug information journal. 2002, Vol 36, Num 2, pp 407-415, issn 0092-8615, 9 p.Article

Managing a crisis effectively: A blueprint for pharmaceutical companiesSTOTKA, Jennifer L; MILLER, Mary Alice.Drug information journal. 2002, Vol 36, Num 2, pp 325-331, issn 0092-8615, 7 p.Article

Patient-reported outcomes: The example of health-related quality of life: A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory processCHASSANY, Olivier; SAGNIER, Pierre; MARQUIS, Patrick et al.Drug information journal. 2002, Vol 36, Num 1, pp 209-238, issn 0092-8615, 30 p.Article

Pharmacovigilance licensing: The role of drug safety in product transfersBECKER, Martin Karl.Drug information journal. 2002, Vol 36, Num 3, pp 667-671, issn 0092-8615, 5 p.Article

Report of a workshop on confirmatory evidence to support a single clinical trial as a basis for new drug approvalPECK, Carl C; WECHSLER, Jill.Drug information journal. 2002, Vol 36, Num 3, pp 517-534, issn 0092-8615, 18 p.Article

The impact of the implementation of the international conference on harmonisation essential documents on investigator sitesICART, Luis Pena; TORRES GEMEIL, Olga J; CEVALLOS, Jose et al.Drug information journal. 2002, Vol 36, Num 4, pp 743-750, issn 0092-8615, 8 p.Article

The theory of constraints: A unique alternative to traditional project managementKANIA, Eugene; HOUSDEN, Gayle; HITCHNER, Ken et al.Drug information journal. 2002, Vol 36, Num 3, pp 611-621, issn 0092-8615, 11 p.Article

What type of pivotal study design is appropriate for an investigational new drug to manage chronic angle closure glaucoma: Active control or placebo?LIN, Yeong-Liang; MAU, Bey-Liing; CHERN, Herng-Der et al.Drug information journal. 2002, Vol 36, Num 3, pp 499-500, issn 0092-8615, 2 p.Article

Working with regulations in foreign countries, with emphasis on good manufacturing practice for herbal medicinesSCHOLTEN, Willem K.Drug information journal. 2002, Vol 36, Num 1, pp 51-55, issn 0092-8615, 5 p.Article

Ethical considerations in clinical trials in Asia : Evolution of drug regulatory process in AsiaTANIDA, Noritoshi.Drug information journal. 2002, Vol 36, Num 1, pp 41-49, issn 0092-8615, 9 p.Conference Paper

Criteria to request pharmacoeconomic data and data sources for hospital formulary decisionsKULSOMBOON, Vithaya; PALUMBO, Francis B; MULLINS, C. Daniel et al.Drug information journal. 2001, Vol 35, Num 1, pp 231-240, issn 0092-8615Article

Similarities and differences between the United States and Europe in the development of fixed combination products for the treatment of hypertensionALEXANDER, John; PUCCHLER, Kurt.Drug information journal. 2001, Vol 35, Num 2, pp 599-605, issn 0092-8615Article

Something for nothing in noninferiority/superiority testing: A cautionWIENS, Brian L.Drug information journal. 2001, Vol 35, Num 1, pp 241-245, issn 0092-8615Article

The emerging role of medical affairs within the modern pharmaceutical companyWOLIN, Maurice J; AYERS, Priscilla M; CHAN, Elaine K et al.Drug information journal. 2001, Vol 35, Num 2, pp 547-555, issn 0092-8615Article

Training medical writers in Today's environment 3: How to please a medical writerWOOLLEY, Paul; SEILER, Walther.Drug information journal. 2001, Vol 35, Num 1, pp 259-268, issn 0092-8615Article